- Home
- NEGG vs DCTH Comparison
NEGG vs DCTH Comparison
Compare NEGG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- DCTH
- Stock Information
- Founded
- NEGG 2001
- DCTH 1988
- Country
- NEGG United States
- DCTH United States
- Employees
- NEGG N/A
- DCTH N/A
- Industry
- NEGG Other Specialty Stores
- DCTH Medical/Dental Instruments
- Sector
- NEGG Consumer Discretionary
- DCTH Health Care
- Exchange
- NEGG Nasdaq
- DCTH Nasdaq
- Market Cap
- NEGG 180.8M
- DCTH 352.0M
- IPO Year
- NEGG 2010
- DCTH N/A
- Fundamental
- Price
- NEGG $0.47
- DCTH $11.94
- Analyst Decision
- NEGG
- DCTH Strong Buy
- Analyst Count
- NEGG 0
- DCTH 4
- Target Price
- NEGG N/A
- DCTH $21.50
- AVG Volume (30 Days)
- NEGG 781.8K
- DCTH 346.0K
- Earning Date
- NEGG 01-07-2025
- DCTH 11-08-2024
- Dividend Yield
- NEGG N/A
- DCTH N/A
- EPS Growth
- NEGG N/A
- DCTH N/A
- EPS
- NEGG N/A
- DCTH N/A
- Revenue
- NEGG $1,391,833,000.00
- DCTH $22,644,000.00
- Revenue This Year
- NEGG $6.01
- DCTH $1,605.13
- Revenue Next Year
- NEGG N/A
- DCTH $111.67
- P/E Ratio
- NEGG N/A
- DCTH N/A
- Revenue Growth
- NEGG N/A
- DCTH 945.91
- 52 Week Low
- NEGG $0.43
- DCTH $3.70
- 52 Week High
- NEGG $1.45
- DCTH $13.30
- Technical
- Relative Strength Index (RSI)
- NEGG 31.24
- DCTH 51.68
- Support Level
- NEGG $0.43
- DCTH $10.75
- Resistance Level
- NEGG $0.66
- DCTH $11.59
- Average True Range (ATR)
- NEGG 0.05
- DCTH 0.70
- MACD
- NEGG -0.01
- DCTH -0.11
- Stochastic Oscillator
- NEGG 9.30
- DCTH 24.56
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.